Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Pennsylvania–sponsored t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Lung Adenocarcinoma
• Ovarian Cancer
• Peritoneal Carcinoma
• Peritoneal Mesothelioma
• Pleural Mesothelioma

Drugs mentioned

• Mesothelin-targeted CAR-T cells (CAR-T cells targeting mesothelin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Lung Adenocarcinoma, Ovarian Cancer | Phase 1 | Status: COMPLETED | Results posted: 2025-04-29